|
Marín F, Bonacasa B, Valdés M. Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk? Thromb Haemost. 2010 Jan;103(1):11-2. doi: 10.1160/TH09-10-0694. Epub 2009 Dec 1. PubMed PMID: 20062940.
AÑO: 2010; IF: 6.681
|
20062940
|
Cambronero F, Vilchez JA, García-Honrubia A, Ruiz-Espejo F, Moreno V, Hernández-Romero D, Bonacasa B, González-Conejero R, de la Morena G, Martínez P, Climent V, Valdés M, Marín F. Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy. Thromb Res. 2010 Jul;126(1):e46-50. doi: 10.1016/j.thromres.2010.01.010. Epub 2010 Feb 13. PubMed PMID: 20156645.
AÑO: 2010; IF: 10.407
|
|
Bonacasa B, Hernández I, Fenoy FJ, Quesada T, López B. Effect of tempol on myocardial vascular remodeling in female spontaneously hypertensive rats. Histol Histopathol. 2012 Aug;27(8):1047-54. PubMed PMID: 22763877.
AÑO: 2012; IF: 2.13
|
|
Hernandez M, Hernandez I, Rodriguez F, Pertegal M, Bonacasa B, Salom MG, Quesada T, Fenoy FJ. Endothelial dysfunction in gestational hypertension induced by catechol-O-methyltransferase inhibition. Exp Physiol. 2013 Mar;98(3):856-66. doi: 10.1113/expphysiol.2012.067389. PubMed PMID: 23104937.
AÑO: 2013; IF: 2.858
|
|
Rodriguez F, Bonacasa B, Fenoy FJ, Salom MG. Reactive oxygen and nitrogen species in the renal ischemia/reperfusion injury. Curr Pharm Des. 2013;19(15):2776-94. Review. PubMed PMID: 23092323.
AÑO: 2013; IF: 3.31
|